107 related articles for article (PubMed ID: 26142735)
1. Temozolomide sensitizes stem-like cells of glioma spheres to TRAIL-induced apoptosis via upregulation of casitas B-lineage lymphoma (c-Cbl) protein.
Zhitao J; Long L; Jia L; Yunchao B; Anhua W
Tumour Biol; 2015 Dec; 36(12):9621-30. PubMed ID: 26142735
[TBL] [Abstract][Full Text] [Related]
2. Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide.
Hingtgen S; Ren X; Terwilliger E; Classon M; Weissleder R; Shah K
Mol Cancer Ther; 2008 Nov; 7(11):3575-85. PubMed ID: 19001440
[TBL] [Abstract][Full Text] [Related]
3. TRAIL induces proliferation of human glioma cells by c-FLIPL-mediated activation of ERK1/2.
Vilimanovich U; Bumbasirevic V
Cell Mol Life Sci; 2008 Mar; 65(5):814-26. PubMed ID: 18239851
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus.
Jahan N; Lee JM; Shah K; Wakimoto H
Int J Cancer; 2017 Oct; 141(8):1671-1681. PubMed ID: 28567859
[TBL] [Abstract][Full Text] [Related]
5. E3 ubiquitin-ligase RNF138 may regulate p53 protein expression to regulate the self-renewal and tumorigenicity of glioma stem cells.
Chao Q; Li X; Huang Y
J Cancer Res Ther; 2023 Dec; 19(6):1636-1645. PubMed ID: 38156932
[TBL] [Abstract][Full Text] [Related]
6. The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma.
Ozyerli-Goknar E; Sur-Erdem I; Seker F; Cingöz A; Kayabolen A; Kahya-Yesil Z; Uyulur F; Gezen M; Tolay N; Erman B; Gönen M; Dunford J; Oppermann U; Bagci-Onder T
Cell Death Dis; 2019 Nov; 10(12):894. PubMed ID: 31772153
[TBL] [Abstract][Full Text] [Related]
7. Human Glioma Cells Therapy Using ATRA-Induced Differentiation Method to Promote the Inhibitive Effect of TMZ and CCDP.
Li X; Zou Z; Ma E; Feng S; Han S
J Healthc Eng; 2021; 2021():6717582. PubMed ID: 34745507
[TBL] [Abstract][Full Text] [Related]
8. Demethoxycurcumin was superior to temozolomide in the inhibition of the growth of glioblastoma stem cells in vivo.
Leng L; Zhong X; Sun G; Qiu W; Shi L
Tumour Biol; 2016 Oct; ():. PubMed ID: 27757851
[TBL] [Abstract][Full Text] [Related]
9. B3GNT5 is a novel marker correlated with stem-like phenotype and poor clinical outcome in human gliomas.
Jeong HY; Park SY; Kim HJ; Moon S; Lee S; Lee SH; Kim SH
CNS Neurosci Ther; 2020 Nov; 26(11):1147-1154. PubMed ID: 32677340
[TBL] [Abstract][Full Text] [Related]
10. Role of autophagy in regulation of glioma stem cells population during therapeutic stress.
Abbas S; Singh SK; Saxena AK; Tiwari S; Sharma LK; Tiwari M
J Stem Cells Regen Med; 2020; 16(2):80-89. PubMed ID: 33414584
[TBL] [Abstract][Full Text] [Related]
11. Insights into Gene Regulation under Temozolomide-Promoted Cellular Dormancy and Its Connection to Stemness in Human Glioblastoma.
Kubelt C; Hellmold D; Esser D; Ahmeti H; Synowitz M; Held-Feindt J
Cells; 2023 May; 12(11):. PubMed ID: 37296610
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 identified as a modulator of temozolomide resistance in P53 wild-type GBM using a high-throughput shRNA-based synthetic lethality screening.
Ding J; Wu S; Zhang C; Garyali A; Martinez-Ledesma E; Gao F; Pokkulandra A; Li X; Bristow C; Carugo A; Koul D; Yung WA
Am J Cancer Res; 2019; 9(11):2428-2441. PubMed ID: 31815044
[TBL] [Abstract][Full Text] [Related]
13. Suppression of ITPKB degradation by Trim25 confers TMZ resistance in glioblastoma through ROS homeostasis.
Yan Y; Zhou S; Chen X; Yi Q; Feng S; Zhao Z; Liu Y; Liang Q; Xu Z; Li Z; Sun L
Signal Transduct Target Ther; 2024 Mar; 9(1):58. PubMed ID: 38438346
[TBL] [Abstract][Full Text] [Related]
14. Salinomycin potentiates the cytotoxic effects of TRAIL on glioblastoma cell lines.
Calzolari A; Saulle E; De Angelis ML; Pasquini L; Boe A; Pelacchi F; Ricci-Vitiani L; Baiocchi M; Testa U
PLoS One; 2014; 9(4):e94438. PubMed ID: 24740347
[TBL] [Abstract][Full Text] [Related]
15. Chemical Activation and Mechanical Sensitization of Piezo1 Enhance TRAIL-Mediated Apoptosis in Glioblastoma Cells.
Knoblauch SV; Desai SH; Dombroski JA; Sarna NS; Hope JM; King MR
ACS Omega; 2023 May; 8(19):16975-16986. PubMed ID: 37214705
[TBL] [Abstract][Full Text] [Related]
16. Vitamin E δ-tocotrienol sensitizes human pancreatic cancer cells to TRAIL-induced apoptosis through proteasome-mediated down-regulation of c-FLIP
Francois RA; Zhang A; Husain K; Wang C; Hutchinson S; Kongnyuy M; Batra SK; Coppola D; Sebti SM; Malafa MP
Cancer Cell Int; 2019; 19():189. PubMed ID: 31367187
[TBL] [Abstract][Full Text] [Related]
17. MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines.
Malacrida A; Di Domizio A; Bentivegna A; Cislaghi G; Messuti E; Tabano SM; Giussani C; Zuliani V; Rivara M; Nicolini G
Biology (Basel); 2022 Jan; 11(1):. PubMed ID: 35053068
[TBL] [Abstract][Full Text] [Related]
18. Targeting the multidrug and toxin extrusion 1 gene (SLC47A1) sensitizes glioma stem cells to temozolomide.
Batara DC; Park SW; Kim HJ; Choi SY; Ohn T; Choi MC; Park SI; Kim SH
Am J Cancer Res; 2023; 13(9):4021-4038. PubMed ID: 37818053
[TBL] [Abstract][Full Text] [Related]
19. TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers.
Damhofer H; Tatar T; Southgate B; Scarneo S; Agger K; Shlyueva D; Uhrbom L; Morrison GM; Hughes PF; Haystead T; Pollard SM; Helin K
Cell Death Dis; 2024 Apr; 15(4):273. PubMed ID: 38632238
[TBL] [Abstract][Full Text] [Related]
20. A targetable PRR11-DHODH axis drives ferroptosis- and temozolomide-resistance in glioblastoma.
Miao Z; Xu L; Gu W; Ren Y; Li R; Zhang S; Chen C; Wang H; Ji J; Chen J
Redox Biol; 2024 May; 73():103220. PubMed ID: 38838551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
